IL33 and neoplasm: However, in our study, a direct implant of rIL-33 in the developing tumor, which we believe well represents elevated IL-33 levels in the tumor microenvironment, led to increased T cell response and decreased tumor growth suggestive of a global role of IL-33 in activating antitumor immunity.